- Crizotinib may be used in Lewis lung carcinoma: A novel use for crizotinib
PU XIA et al, 2013 CrossRef - Synergistic effects of crizotinib and radiotherapy in experimental EML4–ALK fusion positive lung cancer
Ying Dai et al, 2015, Radiotherapy and Oncology CrossRef - Receptor tyrosine kinase signaling in cancer radiotherapy and its targeting for tumor radiosensitization
Poushali Bhattacharya et al, 2018, International Journal of Radiation Biology CrossRef - Membrane phospholipids, EML4-ALK, and Hsp90 as novel targets in lung cancer treatment.
Andrei Laszlo et al, 2013, Cancer J CrossRef - The preclinical profile of crizotinib for the treatment of non-small-cell lung cancer and other neoplastic disorders
Robert Roskoski, 2013, Expert Opinion on Drug Discovery CrossRef - Crizotinib: a review of its use in the treatment of anaplastic lymphoma kinase-positive, advanced non-small cell lung cancer.
James E Frampton, 2013, Drugs CrossRef - RANK-mediated signaling network and cancer metastasis.
Gina Chia-Yi Chu et al, 0 CrossRef - Concurrent crizotinib and whole-brain radiation for brain metastases in ALK-positive lung adenocarcinoma
Ian G Pinto et al, 2014, Lung Cancer Management CrossRef - Molecular Determinants of Radiation Response in Non–Small Cell Lung Cancer
Sue S. Yom et al, 2015, Seminars in Radiation Oncology CrossRef - Cytotoxicity of curcumin derivatives in ALK positive non-small cell lung cancer
Abigail R. Bland et al, 2019, European Journal of Pharmacology CrossRef - The MET/AXL/FGFR Inhibitor S49076 Impairs Aurora B Activity and Improves the Antitumor Efficacy of Radiotherapy
Céline Clémenson et al, 2017, Mol Cancer Ther CrossRef - FLIP: A Targetable Mediator of Resistance to Radiation in Non–Small Cell Lung Cancer
Kylie A. McLaughlin et al, 2016, Mol Cancer Ther CrossRef - The E3 Ligase CHIP Mediates p21 Degradation to Maintain Radioresistance
Kuntal Biswas et al, 2017, Mol Cancer Res CrossRef - Development and characterization of patient-derived xenografts from non-small cell lung cancer brain metastases
Andrew M. Baschnagel et al, 2021, Sci Rep CrossRef - Combining Radiation Therapy with ALK Inhibitors in Anaplastic Lymphoma Kinase-Positive Non-Small Cell Lung Cancer (NSCLC): A Clinical and Preclinical Overview
Delphine Antoni et al, 2021, Cancers CrossRef - A Six-Gene Prognostic and Predictive Radiotherapy-Based Signature for Early and Locally Advanced Stages in Non-Small-Cell Lung Cancer
Javier Peinado-Serrano et al, 2022, Cancers CrossRef - Kinase inhibitors increase individual radiation sensitivity in normal cells of cancer patients
Tina Jost et al, 2022, Strahlenther Onkol CrossRef - Molecular Radiobiology in Non-Small Cell Lung Cancer: Prognostic and Predictive Response Factors
Javier Peinado-Serrano et al, 2022, Cancers CrossRef - The benefit of co-targeting PARP-1 and c-Met on the efficacy of radiotherapy in wild type BRAF melanoma
Malak Sabbah et al, 2023, Front. Med. CrossRef - null
Rodolfo Chicas-Sett et al, 2023 CrossRef - MET Inhibitor Capmatinib Radiosensitizes MET Exon 14-Mutated and MET-Amplified Non-Small Cell Lung Cancer
Shrey Ramesh et al, 2023, International Journal of Radiation Oncology*Biology*Physics CrossRef